Search for more clinical trials
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
Conditions
Islet Cell Tumor - Pancreatic Cancer - Pancreatic Disease
Conditions: official terms
Pancreatic Diseases - Pancreatic Neoplasms
Conditions: Keywords
recurrent pancreatic cancer, stage I pancreatic cancer, stage II pancreatic cancer, stage III pancreatic cancer, stage IV pancreatic cancer, recurrent islet cell carcinoma, pancreatic alpha cell carcinoma, pancreatic beta islet cell carcinoma, pancreatic delta cell carcinoma, pancreatic G-cell carcinoma
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Prospective
Intervention
Name: medical chart review
Type: Other
Name: survey administration
Type: Other
Name: biospecimen collection
Type: Other
Overall Status
Recruiting
Summary
RATIONALE: Gathering medical information and collecting and storing samples of blood and tissue to test in the laboratory may help doctors develop better ways to screen people at risk for pancreatic cancer or other pancreatic disorders in the future.
PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
PURPOSE: This clinical trial is collecting medical information and tissue samples from patients with pancreatic cancer or other pancreatic disorders.
Detailed Description
OBJECTIVES:
Primary
- To collect clinical data and family histories and blood and/or tissue samples from patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in future studies.
- To collect information regarding food preparation and intake in these patients.
Secondary
- To make available to researchers medical data and biospecimens to enable them to develop better ways to screen people at risk for pancreatic conditions, including pancreatic cancer.
- To investigate genes or substances that increase susceptibility of developing pancreatic conditions.
- To find agents that may help prevent, treat, or cure these conditions.
- To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers.
OUTLINE: This is a multicenter study.
Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record.
Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.
Primary
- To collect clinical data and family histories and blood and/or tissue samples from patients diagnosed with pancreatic diseases, including pancreatic cancer, for use in future studies.
- To collect information regarding food preparation and intake in these patients.
Secondary
- To make available to researchers medical data and biospecimens to enable them to develop better ways to screen people at risk for pancreatic conditions, including pancreatic cancer.
- To investigate genes or substances that increase susceptibility of developing pancreatic conditions.
- To find agents that may help prevent, treat, or cure these conditions.
- To learn whether inherited factors increase the risk of pancreatic diseases, pancreatic cancer, or other cancers.
OUTLINE: This is a multicenter study.
Patients complete two 1-hour surveys assessing health, clinical and family history of pancreatic conditions including cancer, and food preparation and intake. Patients also complete a 15- to 30-minute follow up survey at 6 months and 1 year to assess health, health practices, and family history. A review of the patient's medical information is obtained from the medical record.
Blood samples are collected for future research studies. Oral cells and stool samples may also be collected for future studies.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: DISEASE CHARACTERISTICS:
- Diagnosis or suspicion of at least one of the following:
- Pancreatic cancer
- Pancreatic mass
- Islet cell tumor
- Intraductal papillary mucinous neoplasms (IPMN)
- Hereditary pancreatitis
PATIENT CHARACTERISTICS:
- Able to understand and read English
- Mentally competent and able to provide informed consent
- Has not donated blood within the past 8 weeks
PRIOR CONCURRENT THERAPY:
- At least 7 days since prior blood transfusion
- At least 7 days since prior surgery
- Diagnosis or suspicion of at least one of the following:
- Pancreatic cancer
- Pancreatic mass
- Islet cell tumor
- Intraductal papillary mucinous neoplasms (IPMN)
- Hereditary pancreatitis
PATIENT CHARACTERISTICS:
- Able to understand and read English
- Mentally competent and able to provide informed consent
- Has not donated blood within the past 8 weeks
PRIOR CONCURRENT THERAPY:
- At least 7 days since prior blood transfusion
- At least 7 days since prior surgery
Location
Mayo Clinic Cancer Center
Rochester, Minnesota, United States
Status: Recruiting
Contact: Clinical Trials Office - All Mayo Clinic Locations - 507-538-7623
Start Date
October 2000
Completion Date
August 2016
Sponsors
Mayo Clinic
Source
Mayo Clinic
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page